XML 42 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Values of Assets and Liabilities (Tables)
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of balances of assets and liabilities measured at fair value on a recurring basis
The following tables present the balances of assets and liabilities of Ameriprise Financial measured at fair value on a recurring basis: 
 
September 30, 2016
  
 
Level 1
 
Level 2
 
Level 3
 
Total
  
 
(in millions)
  
Assets
 

 
 

 
 

 
 

  
Cash equivalents
$
30

 
$
2,661

 
$

 
$
2,691

  
Available-for-Sale securities:
 

 
 

 
 

 
 

  
Corporate debt securities

 
15,210

 
1,342

 
16,552

  
Residential mortgage backed securities

 
6,577

 
285

 
6,862

  
Commercial mortgage backed securities

 
3,056

 
33

 
3,089

  
Asset backed securities

 
1,339

 
165

 
1,504

  
State and municipal obligations

 
2,488

 

 
2,488

  
U.S. government and agencies obligations
9

 
1

 

 
10

  
Foreign government bonds and obligations

 
275

 

 
275

  
Common stocks
4

 
10

 

 
14

  
Common stocks measured at NAV
 
 
 
 
 
 
5

(1) 
Total Available-for-Sale securities
13

 
28,956

 
1,825

 
30,799

  
Trading securities
5

 
28

 

 
33

  
Separate account assets measured at NAV
 
 
 
 
 
 
81,511

(1) 
Investments segregated for regulatory purposes
201

 

 

 
201

 
Other assets:
 
 
 
 
 
 
 
 
Interest rate derivative contracts
2

 
3,645

 

 
3,647

  
Equity derivative contracts
58

 
1,394

 

 
1,452

  
Credit derivative contracts

 
1

 

 
1

 
Foreign exchange derivative contracts
5

 
70

 

 
75

  
Other derivative contracts

 
3

 

 
3

  
Total other assets
65

 
5,113

 

 
5,178

  
Total assets at fair value
$
314

 
$
36,758

 
$
1,825

 
$
120,413

  
Liabilities
 
 
 
 
 
 
 
 
Policyholder account balances, future policy benefits and claims:
 

 
 

 
 

 
 

  
EIA embedded derivatives
$

 
$
5

 
$

 
$
5

  
IUL embedded derivatives

 

 
438

 
438

  
GMWB and GMAB embedded derivatives

 

 
1,756

 
1,756

(2) 
Total policyholder account balances, future policy benefits and claims

 
5

 
2,194

 
2,199

(3) 
Customer deposits

 
8

 

 
8

  
Other liabilities:
 

 
 

 
 

 
 

  
Interest rate derivative contracts

 
1,663

 

 
1,663

  
Equity derivative contracts
2

 
1,874

 

 
1,876

  
Foreign exchange derivative contracts
1

 
34

 

 
35

 
Other derivative contracts
1

 
103

 

 
104

 
Other
9

 
8

 
13

 
30

  
Total other liabilities
13

 
3,682

 
13

 
3,708

  
Total liabilities at fair value
$
13

 
$
3,695

 
$
2,207

 
$
5,915

  
(1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. See Note 2 for further information.
(2) The fair value of the GMWB and GMAB embedded derivatives included $1.8 billion of individual contracts in a liability position and $73 million of individual contracts in an asset position.
(3) 
The Company’s adjustment for nonperformance risk resulted in a $764 million cumulative decrease to the embedded derivatives.
 
December 31, 2015
  
 
Level 1
 
Level 2
 
Level 3
 
Total
  
 
(in millions)
  
Assets
 

 
 

 
 

 
 

  
Cash equivalents
$
80

 
$
1,918

 
$

 
$
1,998

  
Available-for-Sale securities:
 

 
 

 
 

 
 

  
Corporate debt securities

 
14,923

 
1,425

 
16,348

  
Residential mortgage backed securities

 
5,755

 
218

 
5,973

  
Commercial mortgage backed securities

 
2,453

 
3

 
2,456

  
Asset backed securities

 
1,134

 
162

 
1,296

  
State and municipal obligations

 
2,290

 

 
2,290

  
U.S. government and agencies obligations
33

 
35

 

 
68

  
Foreign government bonds and obligations

 
224

 

 
224

  
Common stocks
5

 
8

 

 
13

  
Common stocks measured at NAV
 
 
 
 
 
 
5

(1) 
Total Available-for-Sale securities
38

 
26,822

 
1,808

 
28,673

  
Trading securities
6

 
18

 

 
24

  
Separate account assets measured at NAV
 
 
 
 
 
 
80,349

(1) 
Investments segregated for regulatory purposes
401

 

 

 
401

 
Other assets:
 
 
 
 
 
 
 

  
Interest rate derivative contracts

 
1,940

 

 
1,940

  
Equity derivative contracts
92

 
1,495

 

 
1,587

  
Credit derivative contracts

 
2

 

 
2

 
Foreign exchange derivative contracts
2

 
54

 

 
56

  
Other derivative contracts

 
2

 

 
2

  
Total other assets at fair value and NAV
94

 
3,493

 

 
3,587

  
Total assets
$
619

 
$
32,251

 
$
1,808

 
$
115,032

  
 
Liabilities
 

 
 

 
 

 
 

  
Policyholder account balances, future policy benefits and claims:
 

 
 

 
 

 
 

  
EIA embedded derivatives
$

 
$
5

 
$

 
$
5

  
IUL embedded derivatives

 

 
364

 
364

  
GMWB and GMAB embedded derivatives

 

 
851

 
851

(2) 
Total policyholder account balances, future policy benefits and claims

 
5

 
1,215

 
1,220

(3) 
Customer deposits

 
4

 

 
4

  
Other liabilities:
 

 
 

 
 

 
 

  
Interest rate derivative contracts

 
969

 

 
969

  
Equity derivative contracts
47

 
1,946

 

 
1,993

  
Foreign exchange derivative contracts
2

 
16

 

 
18

 
Other derivative contracts

 
96

 

 
96

 
Other
1

 
12

 

 
13

  
Total other liabilities
50

 
3,039

 

 
3,089

  
Total liabilities at fair value
$
50

 
$
3,048

 
$
1,215

 
$
4,313

  
 
(1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. See Note 2 for further information.
(2) 
The fair value of the GMWB and GMAB embedded derivatives included $994 million of individual contracts in a liability position and $143 million of individual contracts in an asset position.
(3) 
The Company’s adjustment for nonperformance risk resulted in a $398 million cumulative decrease to the embedded derivatives.
Summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis
The following tables provide a summary of changes in Level 3 assets and liabilities of Ameriprise Financial measured at fair value on a recurring basis:
 
Available-for-Sale Securities
 
Other Derivative Contracts
 
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Total
 
(in millions)
 
 
Balance, July 1, 2016
$
1,350

 
$
153

 
$

 
$
178

 
$
1,681

 
$
2

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
Net income

 

 

 
1

 
1

(1) 
(2
)
(2) 
Other comprehensive loss
(2
)
 
1

 

 
1

 

 

 
Purchases
20

 
144

 
33

 
12

 
209

 

 
Settlements
(26
)
 
(14
)
 

 

 
(40
)
 

 
Transfers out of Level 3

 
1

 

 
(27
)
 
(26
)
 

 
Balance, September 30, 2016
$
1,342

 
$
285

 
$
33

 
$
165

 
$
1,825

 
$

 
 
 
 
Changes in unrealized losses relating to assets held at September 30, 2016 included in:
 
 
Benefits, claims, losses and settlement expenses
$

 
$

 
$

 
$

 
$

 
$
(2
)
 

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
 
Policyholder Account Balances,
Future Policy Benefits and Claims
 
Other Liabilities
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
 
 
Balance, July 1, 2016
$
408

 
$
1,965

 
$
2,373

 
$

Total (gains) losses included in:
 
 
 
 
 
 
 
Net income
12

(1) 
(280
)
(2) 
(268
)
 

Issues
25

 
77

 
102

 
13

Settlements
(7
)
 
(6
)
 
(13
)
 

Balance, September 30, 2016
$
438

 
$
1,756

 
$
2,194

 
$
13

 
 
 
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2016 included in:
 
 
 
Interest credited to fixed accounts
$
12

 
$

 
$
12

 
$

Benefits, claims, losses and settlement expenses

 
(267
)
 
(267
)
 


(1) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
 
Available-for-Sale Securities
 
Trading Securities
 
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Total
 
(in millions)
 
Balance, July 1, 2015
$
1,509

 
$
279

 
$
44

 
$
135

 
$
1,967

 
$
1

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
Net income
(1
)
 

 

 
1

 

(1) 
(1
)
(1) 
Other comprehensive loss
(3
)
 
(1
)
 

 
2

 
(2
)
 

 
Purchases
124

 
93

 

 
5

 
222

 

 
Settlements
(90
)
 
(14
)
 
(2
)
 
(8
)
 
(114
)
 

 
Transfers out of Level 3

 
(71
)
 
(37
)
 
(13
)
 
(121
)
 

 
Balance, September 30, 2015
$
1,539

 
$
286

 
$
5

 
$
122

 
$
1,952

 
$

 
 
 
Changes in unrealized gains (losses) relating to assets held at September 30, 2015 included in:
 
 
Net investment income
$
(1
)
 
$

 
$

 
$
1

 
$

 
$

 
(1) Included in net investment income in the Consolidated Statements of Operations.
 
Policyholder Account Balances,
Future Policy Benefits and Claims
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, July 1, 2015
$
292

 
$
235

 
$
527

Total (gains) losses included in:
 
 
 
 
 
Net income
(1
)
(1) 
805

(2) 
804

Issues
31

 
69

 
100

Settlements
(5
)
 
(2
)
 
(7
)
Balance, September 30, 2015
$
317

 
$
1,107

 
$
1,424

 
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2015 included in:
Interest credited to fixed accounts
$
(1
)
 
$

 
$
(1
)
Benefits, claims, losses and settlement expenses

 
811

 
811


(1) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.

 
Available-for-Sale Securities
 
Other Derivative Contracts
 
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Total
 
(in millions)
 
 
Balance, January 1, 2016
$
1,425

 
$
218

 
$
3

 
$
162

 
$
1,808

 
$

 
Cumulative effect of change in accounting policies

 

 

 
21

 
21

 

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
Net income
(2
)
 

 

 

 
(2
)
(1) 
(2
)
(2) 
Other comprehensive income
29

 

 

 
(5
)
 
24

 

 
Purchases
34

 
144

 
42

 
28

 
248

 
2

 
Settlements
(144
)
 
(53
)
 
(3
)
 
(1
)
 
(201
)
 

 
Transfers into Level 3

 

 

 
12

 
12

 

 
Transfers out of Level 3

 
(24
)
 
(9
)
 
(52
)
 
(85
)
 

 
Balance, September 30, 2016
$
1,342

 
$
285

 
$
33

 
$
165

 
$
1,825

 
$

 
 

 
Changes in unrealized losses relating to assets held at September 30, 2016 included in:
 
 
Net investment income
$
(1
)
 
$

 
$

 
$

 
$
(1
)
 
$

 
Benefits, claims, losses and settlement expenses

 

 

 

 

 
(2
)
 

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
 
Policyholder Account Balances,
Future Policy Benefits and Claims
 
Other Liabilities
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
 
 
Balance, January 1, 2016
$
364

 
$
851

 
$
1,215

 
$

Total losses included in:
 
 
 
 
 
 
 
Net income
8

(1) 
708

(2) 
716

 

Issues
86

 
215

 
301

 
13

Settlements
(20
)
 
(18
)
 
(38
)
 

Balance, September 30, 2016
$
438

 
$
1,756

 
$
2,194

 
$
13

 
 
 
Changes in unrealized losses relating to liabilities held at September 30, 2016 included in:
Interest credited to fixed accounts
$
8

 
$

 
$
8

 
$

Benefits, claims, losses and settlement expenses

 
830

 
830

 

(1) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
 
Available-for-Sale Securities
 
Trading Securities
 
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Common Stocks
 
Total
 
(in millions)
 
Balance, January 1, 2015
$
1,518

 
$
206

 
$
91

 
$
169

 
$
2

 
$
1,986

 
$
1

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Net income
(2
)
 

 

 
1

 

 
(1
)
(1) 
(1
)
(1) 
    Other comprehensive loss
(9
)
 
(1
)
 

 
2

 

 
(8
)
 

 
Purchases
179

 
312

 
41

 
37

 

 
569

 

 
Settlements
(147
)
 
(36
)
 
(5
)
 
(22
)
 

 
(210
)
 

 
Transfers into Level 3

 

 
6

 

 

 
6

 

 
Transfers out of Level 3

 
(195
)
 
(128
)
 
(65
)
 
(2
)
 
(390
)
 

 
Balance, September 30, 2015
$
1,539

 
$
286

 
$
5

 
$
122

 
$

 
$
1,952

 
$

 
 
 
Changes in unrealized (gains) losses relating to assets held at September 30, 2015 included in:
 
 
Net investment income
$
(2
)
 
$

 
$

 
$
1

 
$

 
$
(1
)
 
$

 
(1) Included in net investment income in the Consolidated Statements of Operations.
 
Policyholder Account Balances,
Future Policy Benefits and Claims
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, January 1, 2015
$
242

 
$
479

 
$
721

Total losses included in:
 
 
 
 
 
    Net income
13

(1) 
426

(2) 
439

Issues
76

 
197

 
273

Settlements
(14
)
 
5

 
(9
)
Balance, September 30, 2015
$
317

 
$
1,107

 
$
1,424

 
Changes in unrealized losses relating to liabilities held at September 30, 2015 included in:
 
Interest credited to fixed accounts
$
13

 
$

 
$
13

Benefits, claims, losses and settlement expenses

 
438

 
438

(1) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
Significant unobservable inputs used in the fair value measurements
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
 
September 30, 2016
 
Fair Value
 
Valuation Technique
 
Unobservable Input
 
Range 
 
Weighted Average
 
(in millions)
 
 
 
 
 
 
 
 
Corporate debt securities (private placements)
$
1,339

 
Discounted cash flow
 
Yield/spread to U.S. Treasuries
 
1.0
%
3.0%
 
1.4%
Asset backed securities
$
14

 
Discounted cash flow
 
Annual short-term default rate
 
4.8%
 
 
 
 
 
 
 
Annual long-term default rate
 
2.5%
 
 
 
 
 
 
 
Discount rate
 
14.0%
 
 
 
 
 
 
 
Constant prepayment rate
 
5.0
%
10.0%
 
9.8%
 
 
 
 
 
Loss recovery
 
36.4
%
63.6%
 
62.7%
IUL embedded derivatives
$
438

 
Discounted cash flow
 
Nonperformance risk (1)
 
89 bps
 
 
GMWB and GMAB embedded derivatives
$
1,756

 
Discounted cash flow
 
Utilization of guaranteed withdrawals (2)
 
0.0
%
75.6%
 
 
 
 

 
 
 
Surrender rate
 
0.1
%
66.4%
 
 
 
 

 
 
 
Market volatility (3)
 
5.4
%
21.6%
 
 
 
 

 
 
 
Nonperformance risk (1)
 
89 bps
 
 
Contingent consideration liability
$
13

 
Discounted cash flow
 
Discount rate
 
9.0%
 
 
 
December 31, 2015
 
Fair Value
 
Valuation Technique
 
Unobservable Input
 
Range 
 
Weighted Average
 
(in millions)
 
 
 
 
 
 
 
 
Corporate debt securities (private placements)
$
1,411

 
Discounted cash flow
 
Yield/spread to U.S. Treasuries
 
1.1
%
3.8%
 
1.6%
IUL embedded derivatives
$
364

 
Discounted cash flow
 
Nonperformance risk (1)
 
68 bps
 
 
GMWB and GMAB embedded derivatives
$
851

 
Discounted cash flow
 
Utilization of guaranteed withdrawals (2)
 
0.0
%
75.6%
 
 
 
 

 
 
 
Surrender rate
 
0.0
%
59.1%
 
 
 
 

 
 
 
Market volatility (3)
 
5.4
%
21.5%
 
 
 
 

 
 
 
Nonperformance risk (1)
 
68 bps
 
 

(1) 
The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives.
(2) 
The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year.
(3) 
Market volatility is implied volatility of fund of funds and managed volatility funds.
Schedule of carrying value and the estimated fair value of financial instruments that are not reported at fair value
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:
 
September 30, 2016
 
 
Carrying Value
 
Fair Value
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(in millions)
 
Financial Assets
 
 
 
 
 
 
 
 
 
 
Mortgage loans, net
$
2,974

 
$

 
$

 
$
3,090

 
$
3,090

 
Policy and certificate loans
835

 

 

 
810

 
810

 
Receivables
1,468

 
115

 
1,358

 
3

 
1,476

 
Restricted and segregated cash
2,761

 
2,761

 

 

 
2,761

 
Other investments and assets
525

 
1

 
468

 
54

 
523

 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Policyholder account balances, future policy benefits and claims
$
11,071

 
$

 
$

 
$
12,083

 
$
12,083

 
Investment certificate reserves
5,639

 

 

 
5,632

 
5,632

 
Brokerage customer deposits
3,806

 
3,806

 

 

 
3,806

 
Separate account liabilities measured at NAV
4,397

 
 
 
 
 
 
 
4,397

(1) 
Debt and other liabilities
3,391

 
183

 
3,298

 
156

 
3,637

 
 
December 31, 2015
 
 
Carrying Value
 
Fair Value
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(in millions)
 
Financial Assets
 
 
 
 
 
 
 
 
 
 
Mortgage loans, net
$
3,359

 
$

 
$

 
$
3,372

 
$
3,372

 
Policy and certificate loans
824

 

 
1

 
803

 
804

 
Receivables
1,471

 
148

 
1,322

 
3

 
1,473

 
Restricted and segregated cash
2,548

 
2,548

 

 

 
2,548

 
Other investments and assets
583

 
1

 
510

 
54

 
565

 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Policyholder account balances, future policy benefits and claims
$
11,523

 
$

 
$

 
$
12,424

 
$
12,424

 
Investment certificate reserves
4,831

 

 

 
4,823

 
4,823

 
Brokerage customer deposits
3,802

 
3,802

 

 

 
3,802

 
Separate account liabilities measured at NAV
4,704

 
 
 
 
 
 
 
4,704

(1) 
Debt and other liabilities
3,173

 
202

 
2,958

 
113

 
3,273

 

(1) 
Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient. See Note 2 for further information.